Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer (Q34572075)

3 August 2017

1 reference

title

Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer (English)

1 reference

Helicobacter pylori gastritis

3 August 2017

0 references

1 reference

N Yamaguchi

1

1 reference

PubMed ID

11905800

3 August 2017

T Kakizoe

series ordinal

2

1 reference

3 August 2017

1 February 2001

1 reference

Lancet Oncology Commission

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

2

1 reference

3 August 2017

88-94

1 reference

Tumour Production in Glandular Stomach of Rat by N-Methyl-N′-Nitro-N-Nitrosoguanidine

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for stomach cancer in Poland

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Relative significance of dietary sources of nitrate and nitrite

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

A case-control study of gastric cancer and diet in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

A case-control study of gastric cancer and diet in northern Kyushu, Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Risk factors for stomach cancer: a population-based case-control study in Shanghai

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Dietary factors and stomach cancer in Spain: a multi-centre case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Time trends of intestinal and diffuse types of gastric cancer in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

A prospective study of atrophic gastritis and stomach cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Helicobacter pylori infection and the risk of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

H pylori and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Long-term sequelae of Helicobacter pylori gastritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Helicobacter pylori and atrophic gastritis: importance of the cagA status

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Proliferating cell nuclear antigen (PCNA) immunostaining in Helicobacter pylori infection: impact of eradication

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Mucosal mitochondrial function and antioxidant defences in patients with gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Helicobacter pylori infection among offspring of patients with stomach cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h pH monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900225-4

7 January 2021

10.1016/S1470-2045(00)00225-4

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11905800